Welcome to our dedicated page for XWELL SEC filings (Ticker: XWEL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering where XWELL鈥檚 next growth airport will be or how COVID-19 testing revenue is trending? Most investors start by hunting through the company鈥檚 SEC disclosures鈥攂ut XWELL鈥檚 filings can span hundreds of pages of lease details, passenger-traffic assumptions, and spa build-out costs. This page streamlines that search, placing every document in one spot and explaining each with plain-language AI summaries.
Start with the XWELL annual report 10-K simplified section to see segment revenue for XpresSpa, Treat, and XpresTest, plus granular risk factors tied to travel demand. Need quicker updates? Our real-time feed flags every XWELL quarterly earnings report 10-Q filing the moment it hits EDGAR, then highlights foot-traffic metrics and cash-flow changes in a concise dashboard.
If you鈥檙e tracking leadership confidence, the XWELL insider trading Form 4 transactions tab shows share purchases or sales minutes after they鈥檙e filed. Prefer a single stream? The platform groups all XWELL Form 4 insider transactions real-time with executive titles so you can spot patterns before the next earnings call.
- XWELL proxy statement executive compensation reveals how bonuses link to spa EBITDA.
- XWELL 8-K material events explained breaks down new airport contracts or lease renegotiations in plain English.
- Interactive charts deliver instant XWELL earnings report filing analysis without manually poring over PDFs.
Powered by Stock Titan鈥檚 AI, every paragraph comes with a one-click 鈥淓xplain鈥� tool鈥攑erfect for understanding XWELL SEC documents with AI. From dividend policy shifts to XWELL executive stock transactions Form 4, we surface what matters so you can make timely, informed decisions.
XWELL SEC filings explained simply鈥攏o more sifting, just answers.
XWELL (XWEL) will hold its 2025 annual meeting virtually on 16 Sept 2025 @ 10:00 a.m. ET. Owners of 4,000 common shares and 5,756,703 Series G preferred (voting on an as-converted basis) will vote on eight proposals:
- Elect five directors.
- Ratify CBIZ CPAs as 2025 auditor (2024 fees $613k).
- Non-binding Say-on-Pay.
- Advisory choice on pay-vote frequency; board favors 鈥渆very three years.鈥�
- Charter amendment to create a two-class board with staggered two-year terms.
- Reverse stock split authorization (1-for-2 to 1-for-20) within one year to regain Nasdaq $1 bid; a deficiency notice was received 13 May 2025 with a cure deadline of 10 Nov 2025.
- Adjournment authority if needed.
Board recommends FOR all items except Proposal 4, where it recommends 鈥淓VERY THREE YEARS.鈥� Record date: 25 Jul 2025; quorum: 33.33% of voting power. Brokers may vote only on auditor, reverse split and adjournment. Reverse split would not alter authorized shares but would proportionally reduce outstanding shares; odd-lot creation, reduced liquidity and potential market-cap decline are cited risks. The classified board could enhance continuity and deter hostile takeovers but limits shareholder influence.
XWELL, Inc. (Nasdaq: XWEL) has filed Amendment No. 3 to its Form S-3 shelf, registering 30,440,060 common shares for resale by prior investors.
The shares relate to a January 14 2025 private placement comprising: (i) 4,000 Series G convertible preferred shares translating into 23,952,096 conversion shares at a floor price of $0.167; (ii) 5,347,594 shares underlying cash-exercise warrants (Series A at $1.496, Series B at $1.7952); and (iii) up to 1,140,370 dividend shares accruing at 8 % per annum, compounded quarterly, through July 2030.
The registered amount equals roughly 557 % of the company鈥檚 outstanding common stock as of June 18 2025, signalling the potential for substantial dilution if all securities are issued. Proceeds from any resale go to the selling stockholders; XWELL would receive funds only if warrants are exercised for cash, earmarked for general corporate purposes. No underwriter is engaged, and sales may occur on Nasdaq or in private transactions.
XWELL is a non-accelerated, smaller-reporting company. Its shares last traded at $0.9039 on June 18 2025.
FAQ
What is the current stock price of XWELL (XWEL)?
What is the market cap of XWELL (XWEL)?
